Vetoquinol
Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products for cattle, pigs, dogs, and cats in Europe, the Americas, and the Asia Pacific region. It offers products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; antibiotics; reproduction; behavior management; internal … Read more
Market Cap & Net Worth: Vetoquinol (VETO)
Vetoquinol (PA:VETO) has a market capitalization of $932.61 Million (€908.56 Million) as of March 18, 2026. Listed on the PA stock exchange, this France-based company holds position #12816 globally and #68 in its home market, demonstrating a -3.27% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Vetoquinol's stock price €77.00 by its total outstanding shares 11799419 (11.80 Million).
Vetoquinol Market Cap History: 2015 to 2026
Vetoquinol's market capitalization history from 2015 to 2026. Data shows growth from $443.39 Million to $932.61 Million (7.05% CAGR).
Index Memberships
Vetoquinol is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
CAC Health Care
FRHC
|
$70.93 Billion | 0.43% | #5 of 36 |
Weight: Vetoquinol's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Vetoquinol Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Vetoquinol's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.68x
Vetoquinol's market cap is 1.68 times its annual revenue
1.02x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
15.46x
Vetoquinol's market cap is 15.46 times its annual earnings
10.35x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $443.39 Million | $342.61 Million | $24.16 Million | 1.29x | 18.36x |
| 2016 | $518.25 Million | $350.35 Million | $27.83 Million | 1.48x | 18.62x |
| 2017 | $694.84 Million | $352.17 Million | $34.83 Million | 1.97x | 19.95x |
| 2018 | $588.44 Million | $367.94 Million | $36.26 Million | 1.60x | 16.23x |
| 2019 | $752.84 Million | $395.99 Million | $28.59 Million | 1.90x | 26.33x |
| 2020 | $983.78 Million | $427.47 Million | $19.22 Million | 2.30x | 51.18x |
| 2021 | $1.56 Billion | $521.27 Million | $62.86 Million | 2.99x | 24.83x |
| 2022 | $1.04 Billion | $539.78 Million | $47.99 Million | 1.93x | 21.73x |
| 2023 | $1.23 Billion | $529.27 Million | $55.56 Million | 2.32x | 22.14x |
| 2024 | $907.17 Million | $539.20 Million | $58.69 Million | 1.68x | 15.46x |
Competitor Companies of VETO by Market Capitalization
Companies near Vetoquinol in the global market cap rankings as of March 18, 2026.
Key companies related to Vetoquinol by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Vetoquinol Historical Marketcap From 2015 to 2026
Between 2015 and today, Vetoquinol's market cap moved from $443.39 Million to $ 932.61 Million, with a yearly change of 7.05%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €932.61 Million | -7.78% |
| 2025 | €1.01 Billion | +11.48% |
| 2024 | €907.17 Million | -26.25% |
| 2023 | €1.23 Billion | +17.97% |
| 2022 | €1.04 Billion | -33.18% |
| 2021 | €1.56 Billion | +58.63% |
| 2020 | €983.78 Million | +30.68% |
| 2019 | €752.84 Million | +27.94% |
| 2018 | €588.44 Million | -15.31% |
| 2017 | €694.84 Million | +34.08% |
| 2016 | €518.25 Million | +16.88% |
| 2015 | €443.39 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Vetoquinol was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $932.61 Million USD |
| MoneyControl | $932.61 Million USD |
| MarketWatch | $932.61 Million USD |
| marketcap.company | $932.61 Million USD |
| Reuters | $932.61 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.